×
2 415
Fashion Jobs
MICHAEL KORS
Stock Manager
CDI · Richmond
MICHAEL KORS
Superviseur Des Ventes st-Bruno/Sales Supervisor pt- st-Bruno
CDI · San Bruno
MICHAEL KORS
Sales Supervisor - Toronto Eaton Centre
CDI · Toronto
MICHAEL KORS
Full-Time Sales Supervisor, Halifax
CDI · Halifax
MICHAEL KORS
ft Sales Supervisor (Square One Mississauga)
CDI · Mississauga
MICHAEL KORS
Superviseur Des Ventes Dix30/Sales Supervisor ft- Dix30
CDI · Brossard
MICHAEL KORS
ft Sales Supervisor - mk Upper Canada (Newmarket)
CDI · Newmarket
MICHAEL KORS
Sales Supervisor
CDI · Edmonton
MICHAEL KORS
Sales Supervisor
CDI · Burlington
MICHAEL KORS
Superviseur Des Ventes Dix30/Sales Supervisor ft- Dix30
CDI · Brossard
ESTEE LAUDER
Associate Consultant - Clinique - Saskatoon, sk
CDI · Saskatoon
ESTEE LAUDER
Associate Consultant - Clinique - Halifax, ns
CDI · Halifax Regional Municipality
ESTEE LAUDER
Quality Operations Manager
CDI · Toronto
ESTEE LAUDER
Associate Consultant - Clinique - Burlington, on
CDI · Ontario
MICHAEL KORS
Superviseur Des Ventes (Troisième Clé) /Sales Supervisor (Third Key)
CDI · Pointe-Claire
MICHAEL KORS
mk-Sales Supervisor
CDI · Vaughan
MICHAEL KORS
Sales Supervisor
CDI · Richmond
MICHAEL KORS
Full Time Sales Supervisor
CDI · Niagara-on-the-Lake
MICHAEL KORS
Sales Supervisor
CDI · Ottawa
MICHAEL KORS
Commis au Contrôle Des Inventaires / Inventory Control Clerk
CDI · Montreal
MICHAEL KORS
Sales Supervisor
CDI · Toronto
TJX CANADA
Loss Prevention Store Investigator, Downtown Toronto
CDI · Toronto
By
Reuters
Published
Mar 26, 2018
Reading time
2 minutes
Share
Download
Download the article
Print
Click here to print
Text size
aA+ aA-

Givaudan launches 1.3 billion euro bid for France's Naturex

By
Reuters
Published
Mar 26, 2018

Swiss fragrance and flavor maker Givaudan plans to launch an offer for French natural ingredients group Naturex  after agreeing to buy a half-billion euro minority stake in the firm.


Givaudan has placed increasing emphasis on natural flavors to align with shifting consumer demand - Photo: Naturex



Givaudan on Monday said it had agreed to buy a 40.6 percent stake in Naturex for 522 million euros ($645.66 million), or 135 euros per share, adding it intends to offer the same price for the remaining outstanding shares in a mandatory cash offer.

The deal values Naturex around 1.3 billion euros ($1.61 billion), or a roughly 42 percent premium over its market capitalization before the deal was announced.

Naturex shares jumped 42 percent to 135 euros in early trading, while Givaudan rose 1.5 percent.

Givaudan did not say in its statement from whom it is buying the shares. Combined, the Lippens and Martel families own about 39 percent of Naturex, according to Reuters data.

“The acquisition of a significant shareholding in Naturex fits fully with our 2020 strategy to expand our offering to deliver natural products to our customers,” Givaudan Chief Executive Gilles Andrier said.

“Naturex further complements our capabilities with its strong portfolio of plant extracts and natural ingredients across the food and beverage, nutrition and health and personal care sectors.”

The Swiss group has placed increasing emphasis on natural flavors to align with shifting consumer demand, growing its offerings through a number of acquisitions in recent years.

But the offer for Naturex, which develops natural ingredients through plant extracts and employees 1,700 people at 16 production sites, far exceeds the acquisition appetite the group recently flagged for bolt-on deals and outstrips the size of its other purchases.

The Avignon-based firm had sales of 405 million euros last year.

“Looking at transaction multiples, Givaudan seems to be paying a full price,” Baader Helvea analyst Andreas von Arx said in a note, adding the deal made strategic sense and compared favorably to a similar acquisition by rival Symrise due to its higher profitability.

“It expands exposures to natural ingredients and adds a sizeable (faster) growing business to the Swiss flavor and fragrance leader,” he said.

Givaudan said the deal, which remains subject to regulatory approval, is fully supported by Naturex’s board and management.

© Thomson Reuters 2022 All rights reserved.